COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics Extends Exchange Offer for Helomics Notes and Warrants
14/03/2019
MINNEAPOLIS, March 14, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc. (AIPT) (“Precision” or “the Company”) today announced the extension of its previously announced offer (the “Exchange Offer”) to holders of [...]
Lobo Genetics and Alcanna Bring Genetic Testing to Alberta Cannabis Consumers
14/03/2019
TORONTO, March 14, 2019 (GLOBE NEWSWIRE) -- Lobo Genetics Inc. (“Lobo”), a leading cannabis healthcare technology company and Alcanna Inc. (“Alcanna”) (TSX: CLIQ), owner of Nova Cannabis and one of the largest private [...]
Anchiano Therapeutics Initiates Process to Voluntarily Delist its Ordinary Shares from the Tel Aviv Stock Exchange
14/03/2019
CAMBRIDGE, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Anchiano Therapeutics Ltd. (Nasdaq and TASE: ANCN) (“Anchiano”) today announced an update with respect to its intention to voluntarily delist its ordinary shares, no [...]
Teligent, Inc. Announces FDA Approval of Desonide Ointment, 0.05%
14/03/2019
BUENA, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), a New Jersey-based specialty generic pharmaceutical company, today announced it has received approval of the Company’s abbreviated new drug [...]
Organovo to Participate in Nash Panel Discussion at 31st Annual Roth Conference
14/03/2019
SAN DIEGO, March 14, 2019 (GLOBE NEWSWIRE) -- Organovo Holdings, Inc. (NASDAQ:ONVO) (“Organovo”) today announced that it will participate in a panel at the 31 st Annual ROTH Conference, being held in Laguna Niguel, Ca. [...]
Myriad’s myPath® Melanoma Test Receives Medicare Coverage
14/03/2019
Test Will Help Patients Receive a Definitive Diagnosis for a Suspicious Skin Lesion Biopsy SALT LAKE CITY, March 14, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a global leader in personalized [...]
Aptinyx to Report Fourth Quarter and Full Year 2018 Financial Results on Thursday, March 21, 2019
14/03/2019
EVANSTON, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Aptinyx Inc. (NASDAQ: APTX), a clinical-stage biopharmaceutical company developing transformative therapies for the treatment of brain and nervous system disorders, [...]
NexTech Brings AR to Healthcare & Cannabis Industries -- CFN Media
14/03/2019
SEATTLE, March 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of [...]
Oxford Biomedica plc: Preliminary results for the year ended 31 December 2018
14/03/2019
Oxford Biomedica plc Preliminary results for the year ended 31 December 2018 Delivery of dual strategy leads to strong financial growth Oxford, UK – 14 March 2019 : Oxford Biomedica plc (LSE: OXB), (“OXB” or “the Group [...]
Cambrex Completes Expansion and Manufacturing Capability Upgrades in Milan
14/03/2019
EAST RUTHERFORD, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- Cambrex Corporation (NYSE: CBM), the leading small molecule company providing drug substance, drug product and analytical services across the entire drug [...]
VBL Therapeutics to Report Fiscal Year 2018 Financial Results on March 28
14/03/2019
TEL AVIV, Israel, March 14, 2019 (GLOBE NEWSWIRE) -- VBL Therapeutics (Nasdaq: VBLT), a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for [...]
Spring Bank Pharmaceuticals to Participate in Jefferies 2019 HBV Summit
14/03/2019
HOPKINTON, Mass., March 14, 2019 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of viral infections, [...]
BioCorRx to Present at the 31st Annual ROTH Conference on March 17-19, 2019
14/03/2019
ANAHEIM, CA, March 14, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- BioCorRx Inc. (OTCQB: BICX) (“Company”) , a developer and provider of advanced solutions in the treatment of substance use disorders, announced today [...]
Integra LifeSciences Announces the Approval of DuraGen® in Japan
14/03/2019
PLAINSBORO, N.J. and TOKYO, March 14, 2019 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (Nasdaq: IART ), a global leader in medical technology, announces the recent approval of DuraGen ® Dural [...]
Stryker acquires OrthoSpace, Ltd.
14/03/2019
Kalamazoo, Michigan, March 14, 2019 (GLOBE NEWSWIRE) -- Stryker (NYSE:SYK) announced today it has completed the acquisition of OrthoSpace, Ltd., a privately held company founded in 2009 and headquartered in Caesarea, [...]
Eton Pharmaceuticals Submits New Drug Application for DS-200
14/03/2019
FDA Previously Granted DS-200 Fast Track Designation DEER PARK, Ill., March 14, 2019 (GLOBE NEWSWIRE) -- Eton Pharmaceuticals, Inc. (Nasdaq: ETON), today announced that the Company has submitted a New Drug Application ( [...]
electroCore Announces Encouraging Research Supporting Key Areas of Clinical Development for its Non-Invasive Vagus Nerve Stimulator, gammaCore™
14/03/2019
Data presented at the 3rd International Brain Stimulation Conference support the use of nVNS for treatment of mild traumatic brain injury and rheumatoid arthritis BASKING RIDGE, N.J., March 14, 2019 (GLOBE NEWSWIRE) -- [...]
iCAD to Present Corporate Overview at the 31st Annual ROTH Conference
14/03/2019
NASHUA, N.H., March 14, 2019 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD), a global medical technology leader providing innovative cancer detection and therapy solutions, today announced that Michael Klein, Chief [...]
Gala Pharmaceutical Starts Construction of Its Long Beach California Testing Facility
14/03/2019
IRVINE, Calif., March 14, 2019 (GLOBE NEWSWIRE) -- IRVINE, Calif., March 13, 2019 (GLOBE NEWSWIRE) -- Gala Pharmaceutical, Inc. ( GLPH ), a provider of cannabis testing in Southern California, today announced that it [...]

Pages